. .
Thursday, September 24th, 2026
Day 1
| 7:15 – 8:15 | Breakfast & Registration |
| 8:15 – 8:20 | Welcoming Address – Dr. Carolyn Owen & Dr. Versha Banerji, CLL Co-Chairs |
8:20 – 10:00 Session 1: – Session Chair: TBD
| 8:20 – 9:00 | Keynote: Management of Early Stage CLL – Best Approach to Active Surveillance – Dr. Alessandra Ferrajoli |
| 9:00 – 9:10 | Questions & Answers |
| 9:10 – 9:30 | Dietary Modifications in CLL – TBD |
| 9:30 – 9:35 | Questions & Answers |
| 9:35 – 9:55 | Discrete Choice Survey – Dr. Sarit Assouline |
| 9:55 – 10:00 | Questions & Answers |
| 10:00 – 10:30 | Coffee Break |
10:30 – 11:45 Session 2: RWE Outcomes – Session Chair: TBD
| 10:30 – 10:50 | CanCLL research group: introduction to real-world collaborative studies – Dr. Alina Gerrie, BCCA |
| 10:50 – 10:55 | Questions & Answers |
| 10:55 – 11:15 | Richter Transformation – Outcomes in Canadian Patients – TBD |
| 11:15 -11:20 | Questions & Answers |
| 11:20 – 11:40 | Real-World CLL/SLL Outcomes in Alberta– Dr. Robert Puckrin |
| 11:40 – 11:45 | Questions & Answers |
| 11:45 – 12:00 | Outcomes of Younger Patients with CLL – Joshua Yi |
| 12:00 – 12:05 | Questions & Answers |
| 12:05 – 1:05 | Lunch |
12:45 – 2:35 Session 3: Relapsed/Refractory Therapy – Session Chair: TBD
| 1:05 – 1:25 | Anti-CD19 CAR T-cell Therapy for CLL – Dr. James Kochenderfer |
| 1:25 – 1:30 | Questions & Answers |
| 1:30 – 1:50 | Increasing Access to Safe and Effective T-Cell Therapies – Dr. Yale Michaels |
| 1:50 – 1:55 | Questions & Answers |
| 1:55 – 2:05 | Real World Outcomes of CAR-T for CLL – Dr. Mazyar Shadman |
| 2:05 – 2:10 | Questions & Answers |
| 2:10 – 2:20 | Role of CAR-T for CLL in Canada – Dr. Carolyn Owen |
| 2:20 – 2:25 | Questions & Answers |
| 2:25 – 2:45 | Coffee Break |
2:45 – 3:40 Session 4: Translational Studies – Session Chair: TBD
| 2:45 – 3:05 | Presentation TBD – Dr. Rene Zahedi |
| 3:05 – 3:10 | Questions & Answers |
| 3:10 – 3:30 | Presentation TBD |
| 3:30 – 3:35 | Questions & Answers |
| 3:35 – 3:50 | Closing Remarks – Dr. Versha Banerji |
| 5:15 – 6:30 | CLL Poster Presentation Reception – Open to All Attendees |
| 6:30 – 6:45 | Smith Family Welcome Poster Awards – Presented by the Smith Family |
| 6:30 – 9:30 | CLL Dinner |
Friday, September 25th, 2026
| 7:15 – 8:00 | Breakfast & Registration |
| 8:00 – 8:05 | Opening Remarks – Dr. Versha Banerji |
| 8:05 – 8:45 | Keynote: Richter Transformation and Novel Treatments – Dr. Mazyar Shadman |
| 8:45 – 8:55 | Questions & Answers |
8:55 – 10:45 Session 5: Translational Studies – Session Chair: TBD
| 8:55 – 9:15 | Targeting ISGylation to Eliminate Venetoclax-Tolerant Persister Cells – Dr. David Spaner |
| 9:15 – 9:20 | Questions & Answers |
| 9:20 – 9:40 | Significance of CXCR3+ T cells in CLL – Dr. Rebecca Dielschneider |
| 9:40 – 9:45 | Questions & Answers |
| 9:45 – 10:05 | Targeting the Lysosomes in the Chronic Lymphocytic Leukemia (CLL) Microenvironment Using a 3D Spheroid Model – Dr. Spencer Gibson |
| 10:05 – 10:10 | Questions & Answers |
| 10:10 – 10:40 | Drivers of Relapse in BTK Inhibitor and Venetoclax Progressed CLL – Dr. Deepa Sampath |
| 10:40 – 10:45 | Questions & Answers |
| 10:45 – 11:05 | Coffee Break |
11:05 – 1:20 Session 5: Part 2 – Session Chair: TBD
| 11:05 – 11:25 | Presentation TBD – Dr. Christopher Oakes |
| 11:25 – 11:30 | Questions & Answers |
| 11:30 – 11:50 | PKN1/TRAF1 axis in CLL – Dr. Ali Abdul-Sater |
| 11:50 – 11:55 | Questions & Answers |
| 11:55 – 12:15 | Presentation TBD – Dr. Aaron Marshall |
| 12:15 – 12:20 | Questions & Answers |
| 12:20 – 12:50 | Presentation TBD – Dr. Sachin Katyal |
| 12:50 – 12:55 | Questions & Answers |
| 12:55 – 1:15 | Genomic Events in Hodgkin Variant – Richter Transformation – TBD |
| 1:15 – 1:20 | Questions & Answers |
| 1:20 – 1:25 | Closing Remarks – Dr. Carolyn Owen |
| 1:25 – 2:30 | Lunch |